the impact of cytogenetics on treatment decisions in aml
Published 1 year ago • 121 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:41
the importance of integrating genomic and cytogenetic data in treatment decisions for aml
-
1:25
the impact of cytogenetics and molecular genetics on outcomes in aml
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
1:45
impact of cytogenetic abnormalities on os following sct in pediatric aml
-
28:19
diagnosis: morphology, flow cytometry, cytogenetics, molecular testing, and risk-stratification
-
46:36
hartmut michel at the gyss 2023: structures of intermediates of cytochrome c oxidase
-
9:09
cd markers
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
1:02
the impact of sequencing in aml
-
1:12
varied outcomes in patients with aml harboring poor-risk cytogenetics with or without tp53 mutation
-
2:12
the impact of genetic abnormalities on treatment decisions in cll
-
1:52
aml: the cytogenetic risk score
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
2:17
understanding the molecular complexity of aml
-
2:41
an overview of the latest advances in hematology
-
1:12
understanding genetic and non-genetic mechanisms involve in aml disease progression
-
4:31
t-all diagnosis: cytogenetics, genomics and risk assessment
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:39
the impact of complex karyotype on post-transplant outcomes in npm1-mutated aml